Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)
| CAPS Rating |
|
|---|---|
| Open | $19.33 |
| Previous Close | $19.41 |
| Daily Range | $18.58 - $19.37 |
| 52-Week Range | $11.41 - $25.99 |
| Market Cap | $529.09M |
| P/E Ratio | 15.80 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 373,878 |
| Average Daily Volume | 0 |
BRLI
VS S&P 500 (SPY)
How do you think BRLI will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BRLI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BRLI News and Commentary
- Is Bio-Reference Laboratories' Cash Machine Slowing Down? – The Motley Fool
- Quest or Labcorp – How About a Smaller Option? – Blogs @ The Motley Fool
- Helical Portfolio - First Year Reveiw II – Blog at The Motley Fool
- Why the Street Should Love LabCorp's Earnings – The Motley Fool
- 3 Stocks to Beat a Recession – The Motley Fool
- Why Did My Stock Just Die? – The Motley Fool
- The Market Just Crushed My Stock! – The Motley Fool
- Get Ready for the Bounce – The Motley Fool
- The 10 Fastest-Growing Health-Care Providers – The Motley Fool
- Here's 1 Reason Quest Diagnostics Looks Weak – The Motley Fool
- Is Quest Diagnostics' Cash Machine Shutting Down? – The Motley Fool
- Here's How LabCorp May Be Failing You – The Motley Fool
- How Fast Is the Cash at LabCorp? – The Motley Fool
- Prepare your Portfolio: Historical Odds of a Double-Dip Recession Hit 50% – NASDAQ
- Prepare Your Portfolio: Historical Odds of a Double-Dip Recession Hit 50% – The Motley Fool
- Is Quest Diagnostics a Stock for the Long Term? – The Motley Fool
- 5-Star Stocks Poised to Pop: LabCorp – The Motley Fool
- Investing 101: Analyzing Sources of Profitability with ROE – NASDAQ
- Wall Street's Buy List – The Motley Fool
- Investing 101: Top 10 Management Teams Boosted by Hedge Fund Buying – NASDAQ
RSS Headlines
Fool UK
